NOVOZYMES BIOINDUSTRIAL A/S - CVR: 24257908

2023, DKK

21.06.2024

Bruttoresultat

-40.804

Primær drift

-40.804

Årets resultat

-4.027'

Aktiver

25.016'

Kortfristede aktiver

178'

Egenkapital

24.977'

Afkastningsgrad

-0 %

Soliditetsgrad

100 %

Likviditetsgrad

460 %

Resultat

21.06.2024

Årsrapport	2023 21.06.2024	2022 08.06.2023	2021 01.07.2022	2020 29.06.2021	2019 24.06.2020	2018 31.05.2019	2017 31.05.2018	2016 29.05.2017	2015 30.05.2016
Nettoomsætning
Bruttoresultat	-40.804	-36.983	-32.188	0	0	0	0	0	0
Resultat af primær drift	-40.804	-36.983	-32.188	-31.604	-37.567	-57.918	-74.165	-77.546	-947.854
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0	0
Finansielle indtægter	4.704	630	0	5.011.713	0	244.006	0	696.219	12.875
Finansieringsomkostninger	-6.270	-15.587	-47.985	-17.426	-2.825	-533.406	-554.629	-485.576	-523.709
Andre finansielle omkostninger	0	0	0	0	0	0	0	0	0
Resultat før skat	-4.036.353	-2.981.940	619.827	2.462.683	-40.392	-4.847.318	-5.528.794	133.097	-1.458.688
Resultat	-4.027.032	-2.970.513	637.465	2.470.893	-31.506	-4.770.908	-5.390.460	254.382	-1.318.202
Forslag til udbytte	0	0	0	0	0	0	0	0	0

Aktiver

21.06.2024

Årsrapport	2023 21.06.2024	2022 08.06.2023	2021 01.07.2022	2020 29.06.2021	2019 24.06.2020	2018 31.05.2019	2017 31.05.2018	2016 29.05.2017	2015 30.05.2016
Kortfristede varebeholdninger	0	0	0	0	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	178.298	207.945	17.638	17.096	8.886	76.410	138.334	121.285	140.486
Likvider	0	0	495.563	515.028	581.735	615.139	279.025	268.416	204.493
Kortfristede aktiver	178.298	207.945	513.201	532.124	590.621	691.549	417.359	389.701	344.979
Immaterielle aktiver og goodwill	0	0	0	0	0	0	0	0	0
Finansielle anlægsaktiver	24.837.414	28.831.397	31.756.827	31.056.827	25.775.503	25.775.503	26.934.066	30.704.365	30.705.365
Materielle aktiver	0	0	0	0	0	0	0	0	0
Langfristede aktiver	24.837.414	28.831.397	31.756.827	31.056.827	25.775.503	25.775.503	26.934.066	30.704.365	30.705.365
Aktiver	25.015.712	29.039.342	32.270.028	31.588.951	26.366.124	26.467.052	27.351.425	31.094.066	31.050.344

Aktiver

21.06.2024

Passiver

21.06.2024

Årsrapport	2023 21.06.2024	2022 08.06.2023	2021 01.07.2022	2020 29.06.2021	2019 24.06.2020	2018 31.05.2019	2017 31.05.2018	2016 29.05.2017	2015 30.05.2016
Forslag til udbytte	0	0	0	0	0	0	0	0	0
Egenkapital	24.976.937	29.003.969	29.474.482	28.837.017	26.366.124	26.397.630	1.168.538	6.558.998	6.304.616
Hensatte forpligtelser	0	0	0	0	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0	0	0	0	0
Anden langfristet gæld			0	0	0	0	0	0	0
Leverandører af varer og tjenesteydelser	38.775	35.373	31.250	31.250	0	31.250	0	0	0
Kortfristede forpligtelser	38.775	35.373	2.795.546	31.250	0	69.422	31.250	31.250	31.217
Gældsforpligtelser	0	0	0	0	0	0	0	0	0
Forpligtelser	0	0	0	0	0	0	0	0	0
Passiver	25.015.712	29.039.342	32.270.028	31.588.951	26.366.124	26.467.052	27.351.425	31.094.066	31.050.344

Passiver

21.06.2024

Nøgletal

21.06.2024

Årsrapport	2023 21.06.2024	2022 08.06.2023	2021 01.07.2022	2020 29.06.2021	2019 24.06.2020	2018 31.05.2019	2017 31.05.2018	2016 29.05.2017	2015 30.05.2016
Afkastningsgrad	-0,2 %	-0,1 %	-0,1 %	-0,1 %	-0,1 %	-0,2 %	-0,3 %	-0,2 %	-3,1 %
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-16,1 %	-10,2 %	2,2 %	8,6 %	-0,1 %	-18,1 %	-461,3 %	3,9 %	-20,9 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-650,8 %	-237,3 %	-67,1 %	-181,4 %	-1.329,8 %	-10,9 %	-13,4 %	-16,0 %	-181,0 %
Soliditestgrad	99,8 %	99,9 %	91,3 %	91,3 %	100,0 %	99,7 %	4,3 %	21,1 %	20,3 %
Likviditetsgrad	459,8 %	587,9 %	18,4 %	1.702,8 %	Na.	996,2 %	1.335,5 %	1.247,0 %	1.105,1 %

Resultat

21.06.2024

Gæld

21.06.2024

Årsrapport

21.06.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 21.06.2024)

Beretning

21.06.2024

Dato for ledelsens godkendelse af årsrapporten:2024-06-07

Ledelsespåtegning:The Executive Board and the Board of Directors have today considered and adopted the Annual Report ofNovozymes BioAg A/S for the financial year 1 January - 31 December 2023. The Annual Report is prepared in accordance with the Danish Financial Statements Act. We consider the accounting policies applied appropriate and the estimates made reasonable. In our opinion, the Financial Statements give a true and fair view of the financial position at 31 December2023 of the Company and of the results of the Company operations for 2023. In our opinion, Management’s Review includes a true and fair account of the matters mentioned and describes the most significant risks and elements of uncertainty facing the Company. We recommend that the Annual Report be adopted at the Annual Shareholders' Meeting.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The purpose of the company is to operate and invest in research and development, production and trade with biological solutions, herunder biotechnological products and processes, as well as any business related to this as determined by the Board of Directors. The company strives to operate on a sustainable and responsibleway, both financially, socially and environmentally.